LDFR
CVS icon

Lehman & Derafelo Financial Resources’s CVS Health CVS Stock Holding History

Lehman & Derafelo Financial Resources’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$10.1M Sell
108,233
-1,609
-1% -$155K 2.99% 8
2022
Q3 		$10.5M Sell
109,842
-900
-0.8% -$89.1K 3.3% 7
2022
Q2 		$10.3M Buy
110,742
+9
+0% +$878 3.17% 8
2022
Q1 		$11.2M Sell
110,733
-971
-0.9% -$102K 3.12% 7
2021
Q4 		$11.5M Sell
111,704
-1,564
-1% -$145K 3.48% 7
2021
Q3 		$9.61M Sell
113,268
-690
-0.6% -$57.8K 3.12% 6
2021
Q2 		$9.51M Sell
113,958
-1,189
-1% -$97.4K 2.6% 7
2021
Q1 		$8.66M Buy
115,147
+61
+0.1% +$4.44K 2.43% 8
2020
Q4 		$7.86M Sell
115,086
-2,971
-3% -$193K 2.35% 8
2020
Q3 		$6.89M Buy
118,057
+6,790
+6% +$422K 2.19% 8
2020
Q2 		$7.23M Buy
111,267
+544
+0.5% +$34.3K 2.52% 7
2020
Q1 		$6.57M Buy
110,723
+2,070
+2% +$138K 2.73% 8
2019
Q4 		$8.07M Buy
108,653
+358
+0.3% +$25.1K 2.9% 7
2019
Q3 		$6.83M Buy
+108,295
New +$6.42M 2.61% 8

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Lehman & Derafelo Financial Resources's CVS Position: Q4 2022 in Review

Lehman & Derafelo Financial Resources reduced its CVS Health (CVS) stake by 1.5% in Q4 2022, selling an estimated $155K and leaving 108,233 shares worth $10.1M. The position accounts for 2.99% of the portfolio, ranked #8.

Lehman & Derafelo Financial Resources first reported a position in CVS in Q3 2019 and has held it in 14 quarters since. The position peaked at $11.5M in Q4 2021. 2,405 funds tracked by Wall St. Rank hold CVS as of Q4 2022.

  • Lehman & Derafelo Financial Resources held 108,233 shares of CVS Health worth $10.1M as of Q4 2022.
  • Lehman & Derafelo Financial Resources sold 1,609 CVS Health shares in Q4 2022, an estimated $155K.
  • CVS Health made up 2.99% of Lehman & Derafelo Financial Resources's portfolio in Q4 2022, its #8 holding.
  • Lehman & Derafelo Financial Resources first reported a position in CVS Health in Q3 2019 and has held it in 14 quarters since.
  • Lehman & Derafelo Financial Resources's CVS Health position peaked at $11.5M in Q4 2021.
  • 2,405 funds tracked by Wall St. Rank held CVS Health as of Q4 2022.

Based on Lehman & Derafelo Financial Resources's 13F filing for Q4 2022, filed 20 Jan 2023.